Biopharmaceuticals Recent News
Cantor Fitzgerald Double Downgrades NewLink Genetics After Incyte's Disappointing Trial
Goldman Sachs On Specialty Pharma: Buy Catalent, Sell Valeant
Street Abandons Genocea On Strategic Shift, CEO Says Oncology Focus Wasn't Sudden
Barron's Picks And Pans: Regeneron, Axalta, Alleghany And More
Xencor Sees Profit-Taking After Big Pre-Market Spike
Vetr Crowd Downgrades Tetraphase
Barclays' Biopharmaceuticals Blueprint For 2016
IPO Outlook: Inotek's Vision For The Future
3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology
BioMarin Weathers The Storm
Gilead Sciences Leads In Rising Short Interest Among Biotechs